SRI Intl gets US$ 6.3 mn NIMH contract for preclinical studies of novel ligands
SRI International, an independent non-profit research and development organization, has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications. Ligands are types of molecules that can be used to perform brain imaging through positron emission tomography (PET), single photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI).
Comments